World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
26213
World Ranking
17451
National Ranking
8738

Overview

Deborah A. Kuban is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research predominantly focuses on aspects of medicine, with a concentration on pulmonary and respiratory medicine, economics and econometrics, oncology, radiology, nuclear medicine and imaging, and radiation.

Their main research topics include:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Advanced Radiotherapy Techniques
  • Urological Disorders and Treatments
  • Radiomics and Machine Learning in Medical Imaging

Deborah A. Kuban has published extensively, with notable papers such as:

  • Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer, 2020, JAMA Network Open
  • Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy, 2020, Brachytherapy
  • Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 Prostate Cancers, 2020, International Journal of Radiation Oncology*Biology*Physics
  • Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data, 2020, Practical Radiation Oncology
  • Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium, 2025, The Lancet Oncology

Their frequent co-authors include:

  • Karen E. Hoffman
  • Chad Tang
  • Steven J. Frank
  • Sean E. McGuire
  • Brian F. Chapin

Deborah A. Kuban's work has appeared in multiple publication venues, the most frequent being:

  • International Journal of Radiation Oncology*Biology*Physics
  • Brachytherapy
  • Practical Radiation Oncology
  • Journal of Clinical Oncology
  • Cancer

Best Publications

  • Quality of life and satisfaction with outcome among prostate-cancer survivors.

    Martin G. Sanda;Rodney L. Dunn;Jeff Michalski;Howard M. Sandler

  • PROSTATE CANCER RADIATION DOSE RESPONSE: RESULTS OF THE M. D. ANDERSON PHASE III RANDOMIZED TRIAL

    Alan Pollack;Gunar K Zagars;George Starkschall;John A Antolak

  • Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

    Deborah A. Kuban;Susan L. Tucker;Lei Dong;George Starkschall

  • Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

    Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky

  • Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy.

    He Wang;Lei Dong;Jennifer O'Daniel;Radhe Mohan

  • Prostate Specific Antigen Best Practice Statement: 2009 Update

    Kirsten L. Greene;Peter C. Albertsen;Richard J. Babaian;H. Ballentine Carter

  • Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

    Michael J. Zelefsky;Deborah A. Kuban;Larry B. Levy;Louis Potters

  • Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

    William U. Shipley;Howard D. Thames;Howard M. Sandler;Gerald E. Hanks

  • The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy

    Stephen F. Kry;Mohammad Salehpour;David S. Followill;Marilyn Stovall

  • Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.

    Renaud de Crevoisier;Susan L. Tucker;Lei Dong;Radhe Mohan

  • Bladder cancer. Clinical practice guidelines in oncology.

    Peter E. Clark;Neeraj Agarwal;Matthew C. Biagioli;Mario A. Eisenberger

  • Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

    Eugene H Huang;Alan Pollack;Larry Levy;George Starkschall

  • Prediction of Erectile Function Following Treatment for Prostate Cancer

    Mehrdad Alemozaffar;Meredith M. Regan;Matthew R. Cooperberg;John T. Wei

  • Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era ☆

    Deborah A Kuban;Howard D Thames;Larry B Levy;Eric M Horwitz

  • Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.

    Stephen F. Kry;Mohammad Salehpour;David S. Followill;Marilyn Stovall

  • Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?

    Deborah A Kuban;Lawrence B. Levy;M. Rex Cheung;Andrew K. Lee

  • Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes

    Radhe Mohan;Xiaodong Zhang;He Wang;Yixiu Kang

  • Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

    Howard Thames;Deborah A Kuban;Larry Levy;Eric M. Horwitz

  • PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.

    Michael E. Ray;Howard D. Thames;Larry B. Levy;Eric M. Horwitz

  • Intrafraction prostate motion during IMRT for prostate cancer.

    Eugene Huang;Lei Dong;Anurag Chandra;Deborah A Kuban

Frequent Co-Authors

Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Anthony L. Zietman
Anthony L. Zietman Harvard University
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
Alan Pollack
Alan Pollack University of Miami
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center
Michael J. Zelefsky
Michael J. Zelefsky Memorial Sloan Kettering Cancer Center
Patrick A. Kupelian
Patrick A. Kupelian University of California, Los Angeles
Radhe Mohan
Radhe Mohan The University of Texas MD Anderson Cancer Center
Susan L. Tucker
Susan L. Tucker The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to numerous related online degrees and diverse career pathways. For those already in nursing or looking for advanced clinical roles, you may want to consider a dnp program without clinical hours. These programs are designed for working professionals who seek flexibility and want to advance without traditional on-site requirements.

If you’re eager to enter the nursing field quickly, accelerated lpn programs offer a fast-tracked route to becoming a Licensed Practical Nurse, making it perfect for those who prefer a shorter educational journey.

For registered nurses interested in mental health, bsn to np programs online focus on psychiatric and mental health care. These programs can be completed remotely and usually offer an expedited curriculum for career advancement.

Non-clinical careers are also in high demand. If you are interested in healthcare management, earning a health care administration online degree can lead to leadership roles in hospitals or clinics – all accessible from anywhere.

Best Scientists Citing Deborah A. Kuban

Trending Scientists

Recently Published Articles